Buy or sell CardioFocus stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

CardioFocus Stock

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

About CardioFocus Stock

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.

Funding History

August 1998$2.6M
January 2000$9.6M
August 2001$1.8M
June 2004$10.7M
June 2008$9.1M
June 2009$5.9M
February 2011$30.6M
March 2011$5.0M
May 2013$11.0M
May 2014$2.4M
January 2015$32.0M
May 2016$8.0M
March 2017$20.2M
June 2018$21.0M
May 2019$55.0M
July 2020$12.0M
April 2022$4.0M

Management

CEO & Board Member

Burke T Barrett

Executive Chairman

Paul LaViolette

VP Product Devlopment

Jerry Melsky

VP of Program Management

Rebecca Anderson

Bord of Directors

Michael Wasserman

VP of Operations

Mark Casey

Vice President of Operations

Brian K. Estabrook

Board of Directors

Bruce Robertson

Board Observer

Lisa Granick

Board Director

Paul LaViolette

Director, US Sales

Christopher F. Hallett

VP Sales & Marketing

Karl Firth

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo